Literature DB >> 15979673

Augmented hepatic injury followed by impaired regeneration in metallothionein-I/II knockout mice after treatment with thioacetamide.

Jordan R Oliver1, Sean Jiang, M George Cherian.   

Abstract

A previous study (Oliver, J.R., Mara, T.W., Cherian, M.G. 2005. Impaired hepatic regeneration in metallothionein-I/II knockout mice after partial hepatectomy. Exp. Biol. Med. 230, 61-67) has shown an impairment of liver regeneration following partial hepatectomy (PH) in metallothionein (MT)-I and MT-II gene knockout (MT-null) mice, thus suggesting a requirement for MT in cellular growth. The present study was undertaken to investigate whether MT may play a similar role in hepatic injury and regeneration after acute treatment with thioacetamide (TAA). Hepatotoxicity of TAA is caused by the generation of oxidative stress. TAA was injected ip to both wild-type (WT) and MT-null mice. Mice were killed at 6, 12, 24, 48, 60, and 72 h after injection of TAA (125 mg/kg) or 48 h after injection of saline (vehicle control), and different parameters of hepatic injury were measured. The levels of hepatic lipid peroxidation were increased at 12 h in both types of mice; however, lipid peroxidation was significantly less in WT mice than MT-null mice at 48 h after injection of TAA. Analysis of hepatic glutathione (GSH) levels after TAA injection showed depletion of GSH at 12 h in WT mice and at 6 h in MT-null mice; however, significantly more GSH was depleted early (6-24 h) in MT-null mice than WT mice. An increase in hepatic iron (Fe) levels was observed in both types of mice after injection of TAA, but Fe levels were significantly higher in MT-null mice than WT mice at 6-60 h. The levels of hepatic copper (Cu) and zinc (Zn) were significantly higher in WT mice than MT-null mice at 6-60 h for Cu, and at 24 h and 60 h for Zn, respectively. Histopathological examination showed hemorrhagic necrosis in the liver of both types of mice at 12-72 h, with hepatic injury being more prominent in MT-null mice than WT mice. The hepatic MT levels were increased in WT mice after injection of TAA, and were highest at 24-72 h. Immunohistochemical staining for MT in WT mice indicated the presence of MT in both nucleus and cytoplasm of hepatocytes at 24-72 h after TAA injection. Cell proliferation, as assessed by immunohistochemical staining for proliferating cell nuclear antigen, was detected mainly in the livers of WT mice at 48-72 h after TAA treatment. Hepatic proliferation index in MT-null mice was very low as compared to WT mice during liver regeneration after injection of TAA. These results show that the liver cells of MT-null mice with no functional MT are unable to regenerate after TAA-induced hepatic injury, demonstrating an important role for MT in cellular regeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979673     DOI: 10.1016/j.taap.2005.05.007

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Changes in hepatic gene expression in response to hepatoprotective levels of zinc.

Authors:  Jie Liu; Zhan-Xiang Zhou; Wei Zhang; Matthew W Bell; Michael P Waalkes
Journal:  Liver Int       Date:  2009-03-23       Impact factor: 5.828

2.  Evaluation of metallothionein and Ki-67 expression in chronic cholangiohepatitis in cats.

Authors:  Divya Jose; Andrew L Allen; Barry Blakley; Ahmad Al-Dissi
Journal:  Can J Vet Res       Date:  2021-01       Impact factor: 1.310

3.  Bmi1 enhances skeletal muscle regeneration through MT1-mediated oxidative stress protection in a mouse model of dystrophinopathy.

Authors:  Valentina Di Foggia; Xinyu Zhang; Danilo Licastro; Mattia F M Gerli; Rahul Phadke; Francesco Muntoni; Philippos Mourikis; Shahragim Tajbakhsh; Matthew Ellis; Laura C Greaves; Robert W Taylor; Giulio Cossu; Lesley G Robson; Silvia Marino
Journal:  J Exp Med       Date:  2014-12-01       Impact factor: 14.307

4.  Impact of overexpression of metallothionein-1 on cell cycle progression and zinc toxicity.

Authors:  Paul J Smith; Marie Wiltshire; Emeline Furon; John H Beattie; Rachel J Errington
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-24       Impact factor: 4.249

5.  Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation.

Authors:  Ya-Wei Liu; Yung-Tsung Chiu; Shu-Ling Fu; Yi-Tsau Huang
Journal:  J Biomed Sci       Date:  2015-08-01       Impact factor: 8.410

6.  Alisma Shugan Decoction (ASD) Ameliorates Hepatotoxicity and Associated Liver Dysfunction by Inhibiting Oxidative Stress and p65/Nrf2/JunD Signaling Dysregulation In Vivo.

Authors:  Yunfeng Sun; Honghua Pan; Shenghui Shen; Zhongni Xia; Zhongmin Yu; ChengLe Li; Pingping Sun; Chuanwei Xin
Journal:  Med Sci Monit       Date:  2020-07-16

Review 7.  Genomic and Non-Genomic Mechanisms of Action of Thyroid Hormones and Their Catabolite 3,5-Diiodo-L-Thyronine in Mammals.

Authors:  Marco Giammanco; Carlo Maria Di Liegro; Gabriella Schiera; Italia Di Liegro
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.